Altered immune function in autism

CNS Spectrums

Volumn 2, Issue 5, 1997, Pages 61-68

  Delgiudice Asch, Gina ^a,b,c   Hollander, Eric ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002991204     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900004909     Document Type: Review

References (70)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994:66-71.
2. Kanner L. Autistic disturbances of affective contact. Nerv. Child. 1943;2:217-250.
3. Asperger H. Die autistischen psychopathen in kindersalter. Archiv fur Psychiatrie und Nervenkrankheiten. 1944; 117:76-136.
4. Volkmar FR, Klin A, Siegal B, et al. Field trial for autistic disorder in DSM-IV. Am J Psychiatry. 1994;151:1361-1367.
5. Cook E, Leventhal B. Autistic disorders and other pervasive developmental disorders. Psychiatr Clin North Am. 1995;4:381-399.
6. Singh VK, Fudenberg HH, Emerson D, Coleman M. Immunodiagnosis and immunotherapy in autistic children. Ann NY Acad Sci. 1988;540:602-604.
7. Singh VK, Warren RP, Odell JD, Cole P. Changes of soluble IL-2, IL-2R, T8 antigen and IL-1 in the serum of autistic children. Clin Immunol Immunopathol. 1991;61:448-455.
8. Singh VK, Warren RP, Odell JD, Warren WL, Cole P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun. 1993;7:97-103.
9. Warren RP, Foster A, Margaretten NC, Pace NC. Immune abnormalities in patients with autism. J Autism Dev Disord. 1986;16:189-197.
10. Warren RP, Foster A, Margaretten NC. Reduced natural killer cell activity in autism. J Am Acad Child Adolesc Psychiatry. 1987;26:333-335.
11. Warren RP, Singh VK, Cole P, et al. Increased frequency of the null allele at the complement C4B locus in autism. Clin Exp Immunol. 1991;83:438-440.
12. Warren RP, Yonk LJ, Burger RA, et al. Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism. Immunol Invest. 1990;19:245-251.
13. Weizman A, Weizman R, Szekely GA, Wijsenbeek H, Livini E. Abnormal immune response to brain tissue antigen in the syndrome of autism. Am J Psychiatry. 1982;7:1462-1465.
14. Yonk LJ, Warren RP, Burger RA, et al. CD 4 and helper T cell depression in autism. Immunol Lett. 1990;25:341-346.
15. Gupta S, Aggarwal S, Heads C. Brief report: dysregulated immune system in children with autism; beneficial effects of intravenous immune globulin on autistic characteristics. J Autism Dev Disord. 1996;26:439-452.
16. Zimmerman A, Frye VH, Potter NT. Immunological aspects of autism. Internat J Fed. 1993;8:199-204.
17. Money J, Bobrow NA, Clarke FC, et al. Autism and autoimmune disease: a family study. J Autism Child Schizophr. 1971;1:146-160.
18. Chess S. Autism in children with congential rubella. J Autism Child Schizophr. 1971;1:33-47.
19. Desmond MM, Wilson GS, Melnick JL, et al. Congenital rubella encephalitis - course and early sequelae. J Pediatr. 1967;71:311-331.
20. Knobloch H, Pasamanick B. Gesell and Amatruda's Developmental Diagnosis. 3rd ed. New York, NY: Harper & Row; 1974;320-339.
21. Stubbs EG, Ash E, Williams CPS. Autistic and congenital cytomegalovirus. J Autism Dev Disord. 1984;14:183-189.
22. Peterson MR, Torrey EF. Viruses and other infectious agents as behavioral teratogens. In: Coleman M. ed. The Autistic Syndromes. New York, NY: American Elsevier; 1976:23-42.
23. Stubbs EG. Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination. J Autism Child Schizophr. 1976;6:269-274.
24. Sells CJ, Carpenter RL, Ray CG. Sequelae of central nervous system enterovirus infection. N Engl J Med. 1975;293:1-4.
25. Deykin EY, MacMahon B. Viral exposure and autism. Am J Epidemiol. 1979;109:628-638.
26. Roitt I. Essential Immunology. Oxford. England: Blackwell Scientific Publications; 1991;28-29,32,129-139,325-329.
27. Stubbs EG, Crawford ML. Depressed lymphocyte responsiveness in autistic children. J Autism Child Schizophr. 1977;7:49-55.
28. Ferrari P, Marescot M, Moulias R, et al. Et at immunitaire dans l'autisme infantile. Encephale. 1988;14:339-344.
29. Plioplys AV, Greaves A, Kazemi K, Silverman E. Lymphocyte function in autism and Rett syndrome. Neuropsychobiology. 1994;7:12-16.
30. Morimoto C, Hafler DA, Weiner HL, et al. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. N Engl J Med. 1987;316:67-72.
31. Denney DR, Frei BW, Gaffney GR. Lymphocyte subsets and interleukin-2 receptors in autistic children. J Autism Dev Disord. 1996;26:87-97.
32. Goto M, Tanimoto K, Chihara T, Horiuchi Y. Natural killer cell mediated cytotoxicity in Sjogren's syndrome and rheumatoid arthritis. Arthritis Rheum. 1981;24:1377-1382.
33. Goto M, Tanimoto K, Horiuchi Y. Natural killer cell mediated cytotoxicity in systemic lupus erythematosus. Arthritis Rheum. 1980;23:1274-1281.
34. Walisman BH. Current trends in multiple sclerosis research. Immunol Today. 1981;2:87-93.
35. Ritvo ER, Yuwiler A, Geller E, Ornitz EM, Saeger K, Plotkin S. Increased blood serotonin and platelets in early infantile autism. Arch Gen Psychiatry. 1970;42:129-133.
36. Wright HH, Abramson RK, Self S, Genco P, Cuccaro M. Serotonin may affect lymphocyte cell surface markers in autistic probands. Presented at the American Academy of Child and Adolescent Psychiatry; 1990; San Francisco, Calif. NR Abstract 12.
37. Dawson CA, Llneham JH. Biogenic amines. In: Lenfant C, Masarro D, eds. Lung Biology in Health and Disease, Lung Cell Biology. Vol. 41. New York, NY: Marcel Dekker; 1989:1091.
38. Jackson JC, Cross RJ, Walker F, Markesbery WR, Brooks WH, Roszman TL. Influence of serotonin on the immune responses. Immunology. 1985;54:505.
39. Laberge S, Cruikshank WW, Beer DJ, Center DM. Secretion of IL-6 from serotonin-stimulated CD8+ T cells in vitro. J Immunol. 1996;156:310-315.
40. Husby G, van de Rijn I, Zabriskie JB, Abdin ZH, Williams RC Jr. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med. 1976;144:1094-1110.
41. Plioplys AV, Greaves A, Yoshida W. Anti-CNS antibodies in childhood neurologic diseases. Neuropediatrics. 1989; 20:92-102.
42. Todd RD, Ciaranelio RD. Demonstration of inter- and intraspecies differences in serotonin binding sites by anti-bodies from an autistic child. Proc Natl Acad Sci USA. 1985;82:612-616.
43. Yuwiler A, Shin JS, Chen CH, et al. Hyperserotoninemia and antiserotonin antibodies in autism and other disorders. J Autism Dev Disord. 1992;22:33-45.
44. Cook EH, Perry BD, Dawson G, Wainwright MS, Leventhal BL, et al. Receptor inhibition by immunoglobulins: specific inhibition by autistic children, their relatives, and control subjects. J Autism Dev Disord. 1993;23:67-78.
45. Warren RP, Cole P, Odell JD. et al. Detection of maternal antibodies in infantile autism. J Am Acad Child Adolesc Psychiatry. 1990;29:873-877.
46. Gillberg IC, Gillberg C , Kopp, et al. Hypothyroidism and autism spectrum disorders. J Child Psychol Psychialiatry. 1992;33:531-542.
47. Plioplys AV, Greaves, Kazemi K, Silverman E. Autism: anti-210K neurofilament immunoglobulin reactivity. Neurology. 1989;39(suppl 1):187.
48. Bauman ML, Kemper TL. Limbic and cerebellar abnormalities: consistent findings in infantile autism. J Neuropathol Exp Neurol. 1988;47:369.
49. Bauman ML. Microscopic neuroanatomic abnormalities in autism. Pediatrics. 1991;87:791-796.
50. Todd JA, Acha-Orbea H, Bell JT, et al. A molecular basis for MHC Class H-associated autoimmunity. Science. 1988;240:1003-1009.
51. Stubbs EG, Ritvo ER, Mason-Brothers A. Autism and shared parental HLA antigens. J Am Acad Child Adolesc Pychiatry. 1985;24:182-185.
52. Taylor C, Faulk WP. Prevention of recurrent abortions with leukocyte transfusion. Lancet. 1981;2:68-70.
53. Redman CWG. Immunological aspects of eclampsia and pre-eclampsia. In: Hearn JP, ed. Immunological Aspects of Reproduction and Fertility Control. Lancaster, UK: MTP Press; 1980:52-55.
54. Warren RP, Singh VK, Cole P, et al. Possible association of the extended MHC haplotype B44-SC30-DR4 with autism. Immunogenetics. 1992;36:203-207.
55. Warren RP, Odell JD, Warren WL. et al. Brief report: immunoglobulin A deficiency in a subset of autistic subjects. J Autism Dev Disord. 1997;27:187-192.
56. Moreno H, Brijas L, Arrilta A, et al. Heterogeneidad clinica del sindrome autista: un estudio en sesenta familias. Invest Clin. 1992;33:13-31.
57. Suzuki M, Nakazima K, Sugiyama A, Nakashita Y, Ogawa T, et al. On the effects of pentoxifylline upon the EEG activity of early infantile autism: quantitative pharmaco-electroencephalographic study. Brain Dev. 1984;6:156.
58. Selman K, Reine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol. 1988;23:339-346.
59. Brosnan CF, Selmaj K, Raines CS. Hypothesis: a role for TNF in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol. 1988;18:87-94.
60. Natal S, Louboutin JP, Chabannes D, et al. Pentoxifylline inhibits experimental allergic encephalitis. Acta Keurol Scand. 1993;88:97-99.
61. Black RS, Barclay LL, Nolan KA. Pentoxifylline in cerebrovascular dementia. J Am Geriatr Soc. 1992;40:237-244.
62. Sogame S. On our experience in using pentoxifylline for abnormal behavior and the autistic syndrome. Japanese Journal of Child Psychiatry. 1978;19:134-144.
63. Nakane A. Effect of pentoxifylline on autistic children. Tokyoto Eisei Gakkashi. 1980;64:104-105.
64. Shimoide M. Effect of pentoxifylline on infantile autism. Clin Exp Med. 1981;58:285-288.
65. Turek S. Treatment of psychotic and autistic children with pentoxifylline. ASANA. 1981;1:51-60.
66. Dwyer JM. Manipulating the immune system with immunoglobulin. N Engl J Med. 1992;326:4104-4109.
67. Nevsimalova S, Tauberova A, Doutlik S, Kucera V, Dlouha O. A role for autoimmunity in the etiopalhogenesis of Landau-Kleffner Syndrome? Brain Dev. 1992;14:342-345.
68. Cole AJ, Andermann F, Taylor L. et al. The Landau-Kleffner syndrome of acquired epileptic aphasia: unusual clinical outcome, surgical experience, and absence of encephalitis. Neurology. 1988;38:31-38.
69. Tuchman RF. Epilepsy, language and behavior: clinical models in childhood. J Child Neurol. 1994;9:95-102.
70. Paquier PF, Van Dongen HR, Loonen CB. The Landau-Kleffner syndrome or acquired aphasia with convusive disorder. Arch Neurol. 1992;49:354-359.